Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and remarkably improved user experience BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. – Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch [...]

Corning launches HepGo™ assay-ready 3D liver spheroid kits

Corning expands cell culture portfolio with 3D liver models that better recapitulate in vivo behavior and deliver a more physiologically relevant model for improved drug safety and efficacy screening CORNING, N.Y. -- Corning Incorporated (NYSE: GLW) today announced the launch of its HepGo™ Assay-ready 3D liver spheroid kit, the first plug-and-play solution to include 96 [...]

Zai Lab selects ENPICOM’s IGX Platform to leverage new NGS-powered antibody discovery workflows

Zai Lab will use ENPICOM’s Antibody Discovery Module to expand its pipeline of innovative drugs and discover new therapeutic candidates s-Hertogenbosch, The Netherlands – ENPICOM, an innovative bioinformatics software engineering company, announced today that Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative, research-based, commercial-stage biopharmaceutical company based in China and the U.S., has signed [...]

RIGAKU AND JEOL LAUNCH A REVOLUTIONARY ELECTRON DIFFRACTION PLATFORM XTALAB SYNERGY-ED

A Turnkey Solution for Molecular Structure Determination for Nanocrystals Rigaku Corporation (Headquarters: Akishima, Tokyo, Japan; Chairman & CEO: Hikaru Shimura), a leading company producing X-ray analysis instruments, and JEOL Ltd. (Headquarters: Akishima, Tokyo, Japan; President & COO: Izumi Oi), a leading company producing electron microscopes and other analytical instruments, have announced the launch of the [...]

Esco Lifesciences closes a Record Setting US$200M Series A Round led by Vivo Capital and Novo Holdings

Largest private fundraising round by an Asia-based life sciences tools company SINGAPORE -- Esco Lifesciences ("Esco", the "Company") announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, [...]

Cytiva and Multiply Labs collaborate to automate cell therapy manufacturing

• Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibility • Automation readily used in other industries is now being tested in the cell therapy workflow • Technology has the potential to transform global healthcare as more cell therapies receive regulatory approval around the [...]

Lexogen gains ISO 9001:2015 quality management certification

Vienna – Lexogen, company of RNA Experts, is honored to announce that it has earned ISO 9001:2015 certification from TÜV Austria CERT GmbH for its quality management system, encompassing the research, development and production of RNA analysis solutions, and the provision of bioinformatics solutions and services for RNA analysis. ISO 9001:2015 is a globally recognized quality [...]

Eagle Genomics bolsters its senior team with 2 new appointments

Both deeply experienced in working with advanced life sciences technology, David Bennett joins as VP Commercial Operations and Sandra Bläser as VP of Customer Success, to satisfy strong demand for Eagle Genomics’ microbiome discovery platform as global brands strive to create sustainable next-gen products Cambridge, UK – Eagle Genomics, a pioneer in applying network science [...]

Rapid Removal of gDNA from RNA Samples

Porvair Sciences has launched Chromatrap® gDNA Removal Columns that quickly remove unwanted genomic DNA (gDNA) from RNA samples. Removal of gDNA from RNA samples is of particular important to scientists undertaking RT-PCR, RNA-seq and microarray-based applications where the high purity and accurate measurement of RNA is vital. Employing a simple load and spin method the [...]

IsoPlexis acquires extensive DNA and RNA sequencing portfolio to enable integrated single-cell sequencing and proteomic solutions

The integration of the sequence of each single cell coupled with IsoPlexis' proprietary functional proteomics accelerates insights into discovery biology & development of advanced medicines BRANFORD, Conn. -- IsoPlexis, the leader in functional single-cell proteomics, today announced the acquisition of an extensive intellectual property portfolio of 86 patents related to DNA and RNA sequencing. These nucleic [...]

Access IBO on Knowledge Center